Kodiak Sciences Inc (KOD)

03:10 AM

Kodiak Sciences Inc. (NASDAQ:KOD) Shares Purchased by Barclays PLC - Defense World

03:10 AM

Jan 20, 2025

Short Interest in Kodiak Sciences Inc. (NASDAQ:KOD) Rises By 8.1% - Defense World

Jan 20, 2025

Jan 20, 2025

Contrasting Cidara Therapeutics (NASDAQ:CDTX) and Kodiak Sciences (NASDAQ:KOD) - Defense World

Jan 20, 2025

Jan 19, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Up 8.1% in December - MarketBeat

Jan 19, 2025

Jan 15, 2025

Jane Street Group LLC Has $90,000 Stock Position in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Jan 15, 2025

Jan 13, 2025

Here’s Why Kodiak Sciences Inc. (KOD) Is Skyrocketing - MSN

Jan 13, 2025

Jan 13, 2025

Why These 24 Stocks Are Skyrocketing - Insider Monkey

Jan 13, 2025

Jan 13, 2025

KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates - MSN

Jan 13, 2025

Jan 10, 2025

Diabetic Retinopathy Global Clinical Trials Review 2024: Region, country (G7 & E7), phase, trial status, End-points Status and Sponsor Type - GlobeNewswire Inc.

Jan 10, 2025

Jan 09, 2025

Geode Capital Management LLC Acquires 12,783 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Jan 09, 2025

Jan 07, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Shares Acquired by Barclays PLC - Defense World

Jan 07, 2025

Jan 07, 2025

Kodiak Sciences CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 07, 2025

Jan 02, 2025

Crude Oil Surges 2%; Tesla Shares Plummet - Benzinga

Jan 02, 2025

Jan 02, 2025

Kodiak Sciences (NASDAQ:KOD) Shares Down 2.9%Here's What Happened - MarketBeat

Jan 02, 2025

Jan 02, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Shares Purchased by State Street Corp - Defense World

Jan 02, 2025

Jan 01, 2025

Sanctuary Advisors LLC Reduces Holdings in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Jan 01, 2025

Dec 30, 2024

Age-related Vision Dysfunction Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Epidemiology, Therapies, Treatment, Companies by DelveInsight - The Globe and Mail

Dec 30, 2024

Dec 28, 2024

Institutional investors have a lot riding on Kodiak Sciences Inc. (NASDAQ:KOD) with 43% ownership - Yahoo Finance

Dec 28, 2024

Dec 27, 2024

Kodiak Sciences (NASDAQ:KOD) Trading Down 7.5%Time to Sell? - MarketBeat

Dec 27, 2024

Dec 24, 2024

Kodiak Sciences (NASDAQ:KOD) Trading 6.7% HigherStill a Buy? - MarketBeat

Dec 24, 2024

Dec 23, 2024

Kodiak Sciences (NASDAQ:KOD) Shares Gap UpTime to Buy? - MarketBeat

Dec 23, 2024

Dec 23, 2024

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 23, 2024

Dec 19, 2024

Kodiak Sciences Inc. (NASDAQ:KOD) Shares Bought by Fmr LLC - Defense World

Dec 19, 2024

Dec 18, 2024

Deal Watch: Merck Decides Better Late Than Never In GLP-1 Deal With Hansoh - Citeline News & Insights

Dec 18, 2024

Dec 15, 2024

Kodiak Sciences' SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com South Africa

Dec 15, 2024

Dec 15, 2024

Kodiak Sciences' SWOT analysis: biotech stock faces pivotal year ahead - Investing.com India

Dec 15, 2024

Dec 15, 2024

Critical Survey: Allogene Therapeutics (NASDAQ:ALLO) versus Kodiak Sciences (NASDAQ:KOD) - Defense World

Dec 15, 2024

Dec 13, 2024

Nona Biosciences and Kodiak Sciences Partner on Next-Generation Antibody Therapies for Ophthalmic Diseases - The Eastern Progress Online

Dec 13, 2024

Dec 13, 2024

We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate - Simply Wall St

Dec 13, 2024

Dec 10, 2024

KOD Stock Up as Jefferies Upgrades Rating on Huge Pipeline Potential - MSN

Dec 10, 2024

Dec 10, 2024

Nona Biosciences Partners With Kodiak Sciences For Ophthalmic Antibody Discovery - Contract Pharma

Dec 10, 2024

Dec 10, 2024

Nona Biosciences, Kodiak Sciences partner on antibody therapies for ophthalmic diseases - Seeking Alpha

Dec 10, 2024

Dec 10, 2024

Nona Biosciences and Kodiak Sciences Inc. Partners on Next-Generation Antibody Therapies for Ophthalmic Diseases - Marketscreener.com

Dec 10, 2024

Dec 09, 2024

Kodiak Sciences Partners with Nona Biosciences for Novel Eye Disease Antibody Development - StockTitan

Dec 09, 2024

Dec 09, 2024

Kodiak stock rallies 32% after Jefferies upgrades to buy - MSN

Dec 09, 2024

Dec 09, 2024

Jefferies Upgrades Kodiak Sciences (KOD) - MSN

Dec 09, 2024

Dec 09, 2024

Pactiv Evergreen, RealReal, Kodiak Sciences And Other Big Stocks Moving Higher On Monday - Benzinga

Dec 09, 2024

Dec 09, 2024

Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock - Yahoo Finance

Dec 09, 2024

Dec 09, 2024

Kodiak Sciences shares initiated with buy rating on positive outlook By Investing.com - Investing.com South Africa

Dec 09, 2024

Dec 09, 2024

Kodiak stock rallies 32% after Jefferies upgrades to buy (NASDAQ:KOD) - Seeking Alpha

Dec 09, 2024

Dec 09, 2024

Kodiak Sciences shares initiated with buy rating on positive outlook - Investing.com

Dec 09, 2024

Dec 09, 2024

Kodiak Sciences (NASDAQ:KOD) Upgraded to "Buy" at Jefferies Financial Group - MarketBeat

Dec 09, 2024

Dec 09, 2024

Jacobs Levy Equity Management Inc. Sells 118,375 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - MarketBeat

Dec 09, 2024

Dec 07, 2024

Kodiak Sciences stock hits 52-week high at $7.81 By Investing.com - Investing.com Canada

Dec 07, 2024

Dec 06, 2024

Kodiak Sciences stock hits 52-week high at $7.81 - Investing.com India

Dec 06, 2024